Chapter 13. Development of Organic Nitrates for Coronary Heart Disease

  1. Dr. János Fischer2,
  2. Prof. Dr. C. Robin Ganellin3
  1. László Dézsi

Published Online: 22 MAY 2006

DOI: 10.1002/3527608001.ch13

Analogue-based Drug Discovery

Analogue-based Drug Discovery

How to Cite

Dézsi, L. (2006) Development of Organic Nitrates for Coronary Heart Disease, in Analogue-based Drug Discovery (eds J. Fischer and C. R. Ganellin), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG. doi: 10.1002/3527608001.ch13

Editor Information

  1. 2

    Gedeon Richter Ltd., P.O. Box 27, H-1475 Budapest 10, Hungary

  2. 3

    University College London, Department of Chemistry, 20 Gordon Street, London WC1H OAJ, UK

Author Information

  1. Gedeon Richter Ltd, P.O. Box 27, 1475 Budapest 10, Hungary

Publication History

  1. Published Online: 22 MAY 2006
  2. Published Print: 20 JAN 2006

ISBN Information

Print ISBN: 9783527312573

Online ISBN: 9783527608003

SEARCH

Keywords:

  • analogue-based drug discovery;
  • development of organic nitrates for coronary heart disease;
  • empirical observations;
  • therapeutic use of classic nitrovasodilators;
  • Isoamyl nitrite;
  • Nitroglycerin;
  • Isosorbide Dinitrate;
  • Isosorbide Mononitrate;
  • Nicorandil;
  • cardiovascular efficacy;
  • mechanism of action;
  • tolerance to organic nitrates

Summary

This chapter contains sections titled:

  • Introduction

  • Empirical Observations Leading to the Therapeutic Use of Classic Nitrovasodilators

  • Isoamyl Nitrite: The Pioneer Drug

  • Nitroglycerin (Glyceryl Trinitrate): The Most Successful Analogue

  • Isosorbide Dinitrate: A Viable Analogue with Prolonged Action

  • Isosorbide Mononitrate: The Metabolite of Isosorbide Dinitrate

  • Nicorandil: The Potassium Channel Opener Analogue with a Broad Cardiovascular Spectrum

  • Cardiovascular Efficacy of Organic Nitrates

  • Mechanism of Action of Organic Nitrates

  • Tolerance to Organic Nitrates

  • Concluding Remarks